Ultralife (NASDAQ:ULBI) Stock Price Crosses Above 200 Day Moving Average of $8.27

Ultralife Co. (NASDAQ:ULBI - Get Free Report) shares passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $8.27 and traded as high as $9.84. Ultralife shares last traded at $9.58, with a volume of 57,845 shares changing hands.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on ULBI shares. StockNews.com lowered shares of Ultralife from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, March 26th. Benchmark boosted their price objective on shares of Ultralife from $12.00 to $13.00 and gave the stock a "buy" rating in a research report on Tuesday, March 5th.

Read Our Latest Stock Report on ULBI

Ultralife Stock Performance

The stock's 50-day moving average price is $8.80 and its 200 day moving average price is $8.27. The company has a debt-to-equity ratio of 0.19, a current ratio of 3.80 and a quick ratio of 2.02. The firm has a market cap of $148.88 million, a P/E ratio of 20.57 and a beta of 1.26.

Ultralife (NASDAQ:ULBI - Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The technology company reported $0.18 EPS for the quarter. The business had revenue of $44.55 million for the quarter. Ultralife had a net margin of 4.54% and a return on equity of 7.36%.


Hedge Funds Weigh In On Ultralife

A number of institutional investors have recently added to or reduced their stakes in the company. Visionary Wealth Advisors increased its holdings in Ultralife by 0.9% during the fourth quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company's stock worth $7,381,000 after buying an additional 9,997 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Ultralife by 3.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 931,030 shares of the technology company's stock worth $6,350,000 after buying an additional 31,194 shares during the last quarter. Vanguard Group Inc. increased its holdings in Ultralife by 8.1% during the third quarter. Vanguard Group Inc. now owns 509,200 shares of the technology company's stock worth $4,970,000 after buying an additional 38,309 shares during the last quarter. Janney Montgomery Scott LLC increased its holdings in Ultralife by 3.4% during the fourth quarter. Janney Montgomery Scott LLC now owns 399,100 shares of the technology company's stock worth $2,722,000 after buying an additional 13,100 shares during the last quarter. Finally, Renaissance Technologies LLC increased its holdings in Ultralife by 9.6% during the second quarter. Renaissance Technologies LLC now owns 193,690 shares of the technology company's stock worth $937,000 after buying an additional 17,000 shares during the last quarter. 30.68% of the stock is currently owned by institutional investors and hedge funds.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Read More

Should you invest $1,000 in Ultralife right now?

Before you consider Ultralife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.

While Ultralife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Featured Articles and Offers

Search Headlines: